Company news
Shanghai Microport Ep Medtech Co., Ltd. Class A (SSE:688351) news
Shanghai Microport Ep Medtech Co., Ltd. Class A news releases on 6ix. Latest, Sep 8, 2026: "SHANGHAI MICROPORT EP MEDTECH CO., LTD."Announcement…
Press releases & updates
"SHANGHAI MICROPORT EP MEDTECH CO., LTD."Announcement on Participating in the 2026 Semi-annual Collective Performance Briefing for the STAR Market Medical Device and Medical Equipment Industry
September 7, 2026
"SHANGHAI MICROPORT EP MEDTECH CO., LTD."Special Report on the Deposit, Management and Actual Use of Raised Funds for the First Half of 2026
August 27, 2026
"SHANGHAI MICROPORT EP MEDTECH CO., LTD."Announcement on Opening a Special Account of Raised Funds and Signing a Tripartite Supervision Agreement for Deposit of Raised Funds in Special Account
July 27, 2026
"SHANGHAI MICROPORT EP MEDTECH CO., LTD."Announcement on Resolutions of the 1st Extraordinary General Meeting in 2026
July 20, 2026
"SHANGHAI MICROPORT EP MEDTECH CO., LTD."Announcement on Changing Partial Investment Projects Financed by Raised Funds
July 3, 2026
Announcement on Implementation of Dividend Distribution for 2025
June 4, 2026
Announcement on Resolutions of the 2025 Annual General Meeting
May 20, 2026
Notice on Convening the 2025 Annual General Meeting
April 29, 2026
Announcement on 2025 Annual Profit Distribution Plan
March 30, 2026
Preliminary Earnings Estimate for 2025
February 11, 2026
Announcement on Listing and Circulation of Partial Restricted Shares in Initial Public Offering
February 10, 2026
Announcement on Voluntary Disclosure of Some Products Obtaining EU MDR Certification
February 9, 2026
Announcement on Obtaining Medical Device Registration Certificate
February 2, 2026
Announcement on Transferring the Equity of a Joint-stock Subsidiary and Related Party Transactions
December 31, 2025
Announcement on Completing Term Change and Election of Board of Directors and Appointing Senior Management Members and Securities Affairs Representative
December 22, 2025
Notice on Convening the 2nd Extraordinary General Meeting in 2025
December 5, 2025
Announcement on Voluntary Disclosure of the Market Approval of the Single-use Pressure-sensing Cardiac Pulsed Field Ablation Catheter
November 21, 2025
Announcement on Resolutions of the 1st Extraordinary General Meeting in 2025
November 12, 2025
Announcement on Resolutions of the 17th Meeting of the 3rd Board of Supervisors
October 27, 2025
Indicative Announcement on Shareholder Terminating Concerted Action Relationship and Equity Change
September 11, 2025
Announcement on Attending the Semi-annual Collective Performance Briefing for Medical Device and Equipment Companies on SSE STAR Market 2025
September 8, 2025
Announcement on "Corporate Value and Return Enhancement" Action Plan 2025
August 26, 2025
Announcement on Voluntary Disclosure of Semi-annual Earnings Preannouncement for 2025
July 22, 2025
Announcement on Resolutions of the 2024 Annual General Meeting
June 18, 2025
Notice on Convening the 2024 Annual General Meeting
May 27, 2025
Announcement on Convening Performance and Cash Dividend Briefing for 2024 and Q1 2025
May 23, 2025
Report for Q1 2025
April 29, 2025
Announcement on 2024 Annual Profit Distribution Plan
March 27, 2025
Announcement on Preliminary Earnings Estimate for 2024
February 24, 2025
Announcement on the Resignation of Securities Affairs Representative
February 7, 2025
Annual Earnings Preannouncement for 2024
January 24, 2025
Announcement on Resolution of the 1st Extraordinary General Meeting in 2024
December 27, 2024
Notice on Convening the 1st Extraordinary General Meeting in 2024
December 11, 2024
Q3 2024 Report
October 21, 2024
Announcement on Convening the 2024 Semi-annual Performance Briefing
September 24, 2024
Announcement on Correction of the Semi-annual Report in 2024
September 11, 2024
Announcement on Listing and Circulation of Restricted Shares under Strategic Allotment from Initial Public Offering
August 22, 2024
Announcement on Changing Accounting Firm
August 21, 2024
Announcement on Voluntary Disclosure of 2024 Semi-annual Performance Forecast
July 4, 2024
Announcement on Resolutions of 2023 Annual General Meeting
June 18, 2024
Announcement on Reply to Letter of Supervision and Inquiry on Information Disclosure of 2023 Annual Report
June 17, 2024
Announcement on Purchase of Liability Insurance for Company, Directors, Supervisors and Senior Management Members
May 23, 2024
Announcement on Changing Business Scope and Amending "Articles of Association"
April 25, 2024
Announcement on Attending 2023 Annual Collective Performance Meeting for Medical Consumables
April 10, 2024
Announcement on 2023 Annual Profit Distribution Scheme
March 29, 2024
Announcement on 2023 Annual Preliminary Earnings Estimate
February 26, 2024
2023 Annual Performance Forecast
January 30, 2024
Indicative Announcement on Report on Result of Shareholder' Inquiry Transfer and Equity Changes of Shareholding Reduction by Shareholder with Over 5% Shares by 1% and Shareholding Reduction to Less than 5%
January 18, 2024
Announcement on Voluntary Disclosure of Obtaining EU MDR Certification of Columbus 3D Cardiac Electrophysiological Mapping System
January 16, 2024
Indicative Announcement on Pricing of Shareholders' Inquiry Transfer
January 15, 2024